| # | Drug | Count |
|---|---|---|
| 0 | DOCETAXEL | 32 |
| 1 | DOCETAXEL ANHYDROUS | 32 |
| 2 | PACLITAXEL | 28 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 26 |
| 4 | LETROZOLE | 20 |
| 5 | BEVACIZUMAB | 19 |
| 6 | PREDNISONE | 19 |
| 7 | CARBOPLATIN | 18 |
| 8 | PAZOPANIB HYDROCHLORIDE | 18 |
| 9 | DENOSUMAB | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COUMARIN | 1 | 0.0061 |
| 1 | CABAZITAXEL | 11 | 0.0031 |
| 2 | INTERLEUKIN-10 | 1 | 0.0028 |
| 3 | RADIUM RA 223 DICHLORIDE | 14 | 0.0028 |
| 4 | VINORELBINE | 12 | 0.0017 |
| 5 | CETYLPYRIDINIUM CHLORIDE | 1 | 0.0015 |
| 6 | FEBUXOSTAT TABLETS 40 MG | 13 | 0.0012 |
| 7 | TOPICAL ANESTHETIC | 1 | 0.0012 |
| 8 | PEMIGATINIB | 1 | 0.0012 |
| 9 | BENZOCAINE | 1 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 47 |
| 1 | Kinase Inhibitor [EPC] | 43 |
| 2 | Aromatase Inhibitor [EPC] | 36 |
| 3 | Corticosteroid [EPC] | 36 |
| 4 | Platinum-based Drug [EPC] | 31 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 23 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 21 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 19 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 19 |
| 9 | Estrogen Receptor Antagonist [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 1 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 2 | Estrogen Receptor Antagonist [EPC] | 17 | 0.0004 |
| 3 | Autologous Cellular Immunotherapy [EPC] | 2 | 0.0003 |
| 4 | Aromatase Inhibitor [EPC] | 36 | 0.0003 |
| 5 | Somatostatin Analog [EPC] | 2 | 0.0003 |
| 6 | Antimycobacterial [EPC] | 7 | 0.0003 |
| 7 | Microtubule Inhibitor [EPC] | 47 | 0.0003 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 6 | 0.0003 |
| 9 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 6 | 0.0003 |